Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 4 (3,4 dichlorophenyl) 1,2,3,4 tetrahydro N methyl 1 naphthylamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1213991C reveals a copper-catalyzed route for high-purity sertraline intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.